Covagen Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
Covagen General Information
Description
Operator of a biopharmaceutical company intended to focus on therapies for inflammatory diseases and cancer. The company develops a proprietary platform that genetically fuses Fynomer-binding proteins to antibodies, resulting in therapeutics with novel modes of action, enabling clients to facilitate the treatment of rheumatoid arthritis, psoriatic arthritis, and other inflammatory diseases.
Contact Information
Website
covagen.comCorporate Office
- Wagistrasse 25
- 8952 Zurich
- Switzerland
Corporate Office
- Wagistrasse 25
- 8952 Zurich
- Switzerland
Covagen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 25-Aug-2014 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series B) | 09-Dec-2013 | Completed | Pre-Clinical Trials | |||
| 6. Early Stage VC (Series A) | 29-Nov-2010 | Completed | Startup | |||
| 5. Early Stage VC | 08-Jan-2010 | Completed | Startup | |||
| 4. Seed Round | 07-Jan-2010 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2006 | Completed | Startup | |||
| 2. University Spin-Out | 01-Jan-2006 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Covagen Comparisons
Industry
Financing
Details
Covagen Competitors (111)
One of Covagen’s 111 competitors is Adimab, a Venture Capital-Backed company based in Lebanon, NH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adimab | Venture Capital-Backed | Lebanon, NH | ||||
| Annexon Biosciences | Formerly VC-backed | Brisbane, CA | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Solid Biosciences | Formerly VC-backed | Charlestown, MA | ||||
| TME Pharma | Formerly VC-backed | Berlin, Germany |
Covagen Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Andera Partners | PE/Buyout | Minority | ||
| Ascent Biomedical Ventures | Venture Capital | Minority | ||
| Baxter Ventures | Corporate Venture Capital | Minority | ||
| Gimv | PE/Buyout | Minority | ||
| MP Healthcare Venture Management | Corporate Venture Capital | Minority |
Covagen FAQs
-
When was Covagen founded?
Covagen was founded in 2006.
-
Where is Covagen headquartered?
Covagen is headquartered in Zurich, Switzerland.
-
What industry is Covagen in?
Covagen’s primary industry is Drug Discovery.
-
Is Covagen a private or public company?
Covagen is a Private company.
-
What is Covagen’s current revenue?
The current revenue for Covagen is .
-
How much funding has Covagen raised over time?
Covagen has raised $94M.
-
Who are Covagen’s investors?
Andera Partners, Ascent Biomedical Ventures, Baxter Ventures, Gimv, and MP Healthcare Venture Management are 5 of 10 investors who have invested in Covagen.
-
Who are Covagen’s competitors?
Adimab, Annexon Biosciences, CytomX Therapeutics, Solid Biosciences, and TME Pharma are some of the 111 competitors of Covagen.
-
When was Covagen acquired?
Covagen was acquired on 25-Aug-2014.
-
Who acquired Covagen?
Covagen was acquired by Cilag.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process